NZ624714A - Methods for treating gout in patient subpopulations - Google Patents
Methods for treating gout in patient subpopulationsInfo
- Publication number
- NZ624714A NZ624714A NZ624714A NZ62471411A NZ624714A NZ 624714 A NZ624714 A NZ 624714A NZ 624714 A NZ624714 A NZ 624714A NZ 62471411 A NZ62471411 A NZ 62471411A NZ 624714 A NZ624714 A NZ 624714A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methods
- medicament
- treating gout
- renal function
- patient subpopulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/059425 WO2013066352A1 (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ624714A true NZ624714A (en) | 2016-01-29 |
Family
ID=48192536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ624714A NZ624714A (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2775835A4 (https=) |
| JP (1) | JP6047172B2 (https=) |
| KR (1) | KR101848122B1 (https=) |
| CN (1) | CN104066323A (https=) |
| AU (1) | AU2011380509B2 (https=) |
| BR (1) | BR112014010693A2 (https=) |
| CA (1) | CA2859689C (https=) |
| CL (1) | CL2014001156A1 (https=) |
| IL (1) | IL232385A (https=) |
| MX (1) | MX354846B (https=) |
| NZ (1) | NZ624714A (https=) |
| SG (1) | SG11201402027PA (https=) |
| WO (1) | WO2013066352A1 (https=) |
| ZA (1) | ZA201403574B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013155478A1 (en) * | 2012-04-13 | 2013-10-17 | Metabolex, Inc. | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent |
| CN105851522A (zh) * | 2014-07-25 | 2016-08-17 | 许伟琦 | 一种防止尿路结石的饲料 |
| CN105920022A (zh) * | 2016-05-12 | 2016-09-07 | 成都易创思生物科技有限公司 | 一种抗痛风药物复方制剂 |
| KR102666724B1 (ko) * | 2017-10-26 | 2024-05-20 | 오츠카 세이야쿠 가부시키가이샤 | 이노시톨인산 함유 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| ME01294B (me) * | 2007-11-27 | 2013-06-20 | Ardea Biosciences Inc | Nova jedinjenja i kompozicije i metode upotrebe |
-
2011
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 CA CA2859689A patent/CA2859689C/en not_active Expired - Fee Related
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/en not_active Ceased
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko not_active Expired - Fee Related
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/en not_active Withdrawn
-
2014
- 2014-04-30 IL IL232385A patent/IL232385A/en active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2859689C (en) | 2018-05-22 |
| AU2011380509A1 (en) | 2014-05-29 |
| MX2014005399A (es) | 2015-04-08 |
| ZA201403574B (en) | 2015-11-25 |
| SG11201402027PA (en) | 2014-09-26 |
| CN104066323A (zh) | 2014-09-24 |
| AU2011380509B2 (en) | 2016-05-19 |
| MX354846B (es) | 2018-03-22 |
| WO2013066352A1 (en) | 2013-05-10 |
| EP2775835A1 (en) | 2014-09-17 |
| KR20140123927A (ko) | 2014-10-23 |
| JP2014532759A (ja) | 2014-12-08 |
| JP6047172B2 (ja) | 2016-12-21 |
| IL232385A (en) | 2017-10-31 |
| KR101848122B1 (ko) | 2018-04-11 |
| IL232385A0 (en) | 2014-06-30 |
| CA2859689A1 (en) | 2013-05-10 |
| EP2775835A4 (en) | 2015-07-29 |
| BR112014010693A2 (pt) | 2020-11-10 |
| CL2014001156A1 (es) | 2015-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY199017A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy | |
| WO2012081898A3 (ko) | 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 | |
| MX2014001946A (es) | Inhibidores del canal de potasio medularmente externo renal. | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| MY174894A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation | |
| IN2014MN02089A (https=) | ||
| UA115320C2 (uk) | Інгібітори кінази | |
| NZ601167A (en) | Treatment of cardiac conditions | |
| MX363949B (es) | Inhibidor de quinasa. | |
| MX2020010004A (es) | Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos. | |
| CA2837341C (en) | Method of determining vasoreactivity using inhaled nitric oxide | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| AU2011208681A8 (en) | Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease | |
| WO2015095097A3 (en) | Inhibitors of the renal outer medullary potassium channel | |
| EA201390335A1 (ru) | Введение лоркасерина индивидуумам с почечной недостаточностью | |
| MY167216A (en) | Kinase inhibitors | |
| MX2012009600A (es) | Metodo para estabilizar daño de articulacion en sujetos utilizando inhibidores de xantina oxidoreductasa. | |
| NZ624714A (en) | Methods for treating gout in patient subpopulations | |
| JP2014532758A5 (https=) | ||
| FR2961695B1 (fr) | Utilisation de composes dans le traitement ou la prevention de troubles cutanes | |
| EA201491870A1 (ru) | Способ лечения гиперурикемии у больных подагрой с помощью галофената или галофеновой кислоты и противовоспалительного агента | |
| MX2013014398A (es) | Derivados de sulfonamida heterociclicos. | |
| EA201190256A1 (ru) | Способ снижения уровня убиквитинилированных белков | |
| UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| NZ702666A (en) | A method of weight reduction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 04 NOV 2018 BY AJ PARK Effective date: 20160726 |
|
| ASS | Change of ownership |
Owner name: CYMABAY THERAPEUTICS, INC., US Effective date: 20170309 Owner name: DIATEX, INC., NZ Effective date: 20170309 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 04 NOV 2019 BY CPA GLOBAL Effective date: 20180920 |
|
| LAPS | Patent lapsed |